FDA Inspection 1305724 — Dxn Pharmaceutical Sdn Bhd

Dxn Pharmaceutical Sdn Bhd — FEI 3006649152

The FDA completed an inspection of Dxn Pharmaceutical Sdn Bhd on March 6, 2026 in Jitra. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 1 citation was issued during this inspection. Product area: Food/Cosmetics.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
March 6, 2026
Fiscal Year
2026
Product Type
Food/Cosmetics
Project Area
Foodborne Biological Hazards
Location
Jitra (Malaysia)

Citations

IDCFRDescription
2288821 CFR 111.210Master manufacturing record - record requirements